Finally, to elucidate the mechanism of Akt down-regulation, BC cells were treated for 6 h with sorafenib in the presence of 50 nM (Fig. 6C) and 100 nM (data not shown) of the lysosome inhibitor, bafylomycin A (Fig. 6C). Here, AKT1 is linked to breast cancer.